Evidence map›Paper›PMID 37039995›Full record

ReviewMolecular biology reports2023

Neuroprotective potential of biochanin-A and review of the molecular mechanisms involved.

Lovedeep Singh, Navneet Kaur, Rajbir Bhatti

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular biology reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Marine-derived Compounds: A Powerful Platform for the Treatment of Alzheimer's Disease.Central nervous system agents in medicinal chemistry · 2024
    Review
  11. Review
  12. Beneficial Effects ofInternational journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Lovedeep SinghDepartment of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, Punjab, India. lovedeep.e13279@cumail.in.ORCID http://orcid.org/0000-0002-2903-4293
Navneet KaurDepartment of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, Punjab, India.
Rajbir BhattiDepartment of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, Punjab, India.ORCID http://orcid.org/0000-0002-5761-7074
Guru Nanak Dev University · INChandigarh University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biochanin-A is a naturally occurring plant phytoestrogen, which mimics specific the agonistic activity of estrogens. Biochanin-A is known to possess numerous activities, including neuroprotective, anti-diabetic, hepatoprotective, anti-inflammatory, antioxidant, and antimicrobial activities, along with the anticancer activity. Neuroinflammation is thought to play a pivotal pathological role in neurodegenerative disease. Sustained neuroinflammatory processes lead to progressive neuronal damage in Parkinson's and Alzheimer's disease. Activation of PI3K/Akt cascade and inhibition of MAPK signaling cascade have been observed to be responsible for conferring protection against neuroinflammation in neurodegenerative diseases. An increased oxidative stress promotes neuronal apoptosis via potentiating the TLR-4/NF-κB and inhibiting PI3K/Akt signaling mediated increase in pro-apoptotic and decreases in antiapoptotic proteins. Various authors have explored biochanin-A's neuroprotective effect by using various cell lines and animal models. Biochanin-A has been reported to mediate its neuroprotective via reducing the level of oxidants, inflammatory mediators, MAPK, TLR-4, NF-κB, NADPH oxidase, AchE, COX-2 and iNOS. Whereas, it has been observed to increase the level of anti-oxidants, along with phosphorylation of PI3K and Akt proteins. The current review has been designed to provide insights into the neuroprotective effect of biochanin-A and possible signaling pathways leading to protection against neuroinflammation and apoptosis in the central nervous system. This review will be helpful in guiding future researchers to further explore biochanin A at a mechanistic level to obtain useful lead molecules.

Indexed as

Neurodegenerative DiseasesNeuroprotective AgentsAnimalsAnti-Inflammatory AgentsAntioxidantsGenisteinNeuroinflammatory DiseasesNF-kappa BPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktToll-Like Receptor 4Anti-Inflammatory AgentsAntioxidantsbiochanin AGenisteinNeuroprotective AgentsNF-kappa BPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktToll-Like Receptor 4Alzheimer’s diseaseBiochanin-AInflammationNeuroprotectionPI3K/AktTLR-4/MAPK

Identifiers

PMID37039995
OpenAlexW4364351968

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.